Publications by authors named "E Destexhe"

Claim this Profile
A
A platform approach as a plausible option for nonclinical safety assessment of adjuvanted vaccines.
Eric Destexhe

NPJ Vaccines· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Repeat-Dose Toxicity Studies Informative for Safety Assessment of Vaccine Candidates? A Survey of Vaccine Developers.
Cynthia M Rohde, Eric Destexhe, Jan Willem van der Laan, Sarah Gould, Rachel Coe

Int J Toxicol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and Rats.
Alan H Stokes, Camille Planty, Johanne Pion, Philippe Ancian, Alexandra Rogue, Eric Destexhe

Int J Toxicol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effects on female fertility or pre- and postnatal development of offspring in rats after exposure to AS03-adjuvanted recombinant plant-derived virus-like particle vaccine candidate for COVID-19.
Charlotte Dubé, Sarah Paris-Robidas, Iryna Primakova, Eric Destexhe, Brian J Ward

Reprod Toxicol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits.
Éric Destexhe, Émilie Grosdidier, Adèle Bouhraoua, Catherine Thirion-Delalande, Badiaa Bouzya

Regul Toxicol Pharmacol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis